Alemtuzumab as Antirejection Therapy: T Cell Repopulation and Cytokine Responsiveness

BACKGROUND: Alemtuzumab induction therapy in kidney transplant patients results in T cell depletion followed by slow immune reconstitution of memory T cells with reduced immune functions. The kinetics and functional characteristics of T cell reconstitution when alemtuzumab is given during immune act...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouvy, Anne P., Klepper, Mariska, Betjes, Michiel G.H., Weimar, Willem, Hesselink, Dennis A., Baan, Carla C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946521/
https://www.ncbi.nlm.nih.gov/pubmed/27500273
http://dx.doi.org/10.1097/TXD.0000000000000595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946521/
https://www.ncbi.nlm.nih.gov/pubmed/27500273
http://dx.doi.org/10.1097/TXD.0000000000000595

Ejemplares similares